Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Merck & Co (NY:MRK)

100.69 UNCHANGED
Streaming Delayed Price Updated: 7:00 PM EST, Dec 18, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 5,276
Open 100.69
Bid (Size) 100.52 (300)
Ask (Size) 100.69 (100)
Prev. Close 100.69
Today's Range 100.69 - 100.69
52wk Range 73.31 - 105.84
Shares Outstanding 2,531,374,696
Dividend Yield 3.22%
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
AbbVie, Merck, Other Top Drugmakers To Lower Prices Of US Drugs In MFN Deal With Trump Administration: Report ↗
This comes after President Donald Trump urged drugmakers in July to lower drug prices for the U.S. government’s Medicaid program. 
Via Stocktwits
Topics Economy Government
News headline image
This Is the 2nd Priciest Stock Market in 155 Years, Which Makes This High-Yield ETF a Genius Buy for 2026 ↗
This top-shelf exchange-traded fund (ETF) checks all the right boxes for income- and value-seeking investors. 
Via The Motley Fool
Topics Artificial Intelligence ETFs Economy

Performance

YTD
+1.5%
+1.5%
1 Month
+4.4%
+4.4%
3 Month
+23.5%
+23.5%
6 Month
+27.4%
+27.4%
1 Year
+2.4%
+2.4%

More News

Read More
News headline image
The 2022 Playbook Returns: Why Investors are Building a 'Fortress 2026'
Via MarketMinute
Topics Artificial Intelligence Economy World Trade
News headline image
Merck Scores FDA Fast-Track Review For Key Cholesterol And Cancer Drugs With Multibillion-Dollar Potential: Report ↗
Via Stocktwits
News headline image
Novartis US Stock Rises On Reports Of White House Pricing Deal Due Friday — Roche Also In Talks ↗
Via Stocktwits
Topics Government World Trade
News headline image
The Ultimate High-Yield Drug Stock to Buy With $1,000 Right Now ↗
Via The Motley Fool
Topics Intellectual Property
News headline image
KEYTRUDA® (pembrolizumab) Plus Padcev® (enfortumab vedotin-ejfv) Significantly Improved Event-Free Survival, Overall Survival and Pathologic Complete Response Rates for Cisplatin-Eligible Patients with MIBC When Given Before and After Surgery
From Merck & Co., Inc.
Via Business Wire
News headline image
Stock Market Today, Dec. 16: Pfizer Falls After Cutting 2025 Revenue Forecast ↗
Via The Motley Fool
Topics Intellectual Property Stocks
News headline image
Pfizer's Muted 2026 Outlook Sends Ripples Through Pharmaceutical Sector
Via MarketMinute
Topics Intellectual Property
News headline image
Should You Buy the 5 Highest-Paying Dividend Stocks in the Dow Jones Before 2026? ↗
Via The Motley Fool
Topics Bonds Economy Intellectual Property
News headline image
These S&P500 stocks are gapping in today's session ↗
Via Chartmill
News headline image
7 Dividend ETFs to Buy With $2,000 and Hold Forever -- Including the Schwab U.S. Dividend Equity ETF (SCHD) ↗
Via The Motley Fool
Topics ETFs
News headline image
Should You Forget Teva Pharmaceutical and Buy These Unstoppable Stocks Instead? ↗
Via The Motley Fool
Topics Intellectual Property
News headline image
Here Are 2 Affordable Healthcare Stocks to Buy Heading Into 2026 ↗
Via The Motley Fool
Topics Intellectual Property
News headline image
Great Rotation: Tech Exodus Fuels Dow's Record Run While Nasdaq Struggles
Via MarketMinute
Topics Artificial Intelligence Bonds Economy
News headline image
The Green Revolution in Silicon: Semiconductor Manufacturing Embraces Sustainability
Via TokenRing AI
Topics Artificial Intelligence Climate Change Economy
News headline image
Merck Receives Positive EU CHMP Opinion for Expanded Use of WINREVAIR™ (sotatercept) in Adults with Pulmonary Arterial Hypertension (PAH, WHO* Group 1 Pulmonary Hypertension)
From Merck & Co., Inc.
Via Business Wire
News headline image
2 Mega-Cap Stocks with Exciting Potential and 1 We Ignore
Via StockStory
News headline image
Dividend Stocks for 2026: Where to Invest as the Market Cools ↗
Via MarketBeat
News headline image
2 Pharmaceutical Stocks to Buy at a Discount ↗
Via The Motley Fool
Topics Intellectual Property
News headline image
Healthcare Sector Falters: S&P 500's Biggest Loser Amid Broader Market Caution
Via MarketMinute
Topics ETFs Economy Intellectual Property
News headline image
Explore the top gainers and losers within the S&P500 index in today's session. ↗
Via Chartmill
News headline image
Here's 1 Major Catalyst Behind Merck Stock's Recent 3.8% Bump ↗
Via The Motley Fool
News headline image
1 Major Factor Behind the Healthcare Sector's Recent Surge ↗
Via The Motley Fool
News headline image
Should You Buy the 3 Highest-Paying Dividend Stocks in the Dow Jones? ↗
Via The Motley Fool
Topics Economy Stocks

Frequently Asked Questions

Is Merck & Co publicly traded?
Yes, Merck & Co is publicly traded.
What exchange does Merck & Co trade on?
Merck & Co trades on the New York Stock Exchange
What is the ticker symbol for Merck & Co?
The ticker symbol for Merck & Co is MRK on the New York Stock Exchange
What is the current price of Merck & Co?
The current price of Merck & Co is 100.69
When was Merck & Co last traded?
The last trade of Merck & Co was at 12/18/25 07:00 PM ET
What is the market capitalization of Merck & Co?
The market capitalization of Merck & Co is 254.88B
How many shares of Merck & Co are outstanding?
Merck & Co has 255B shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.